Residual intrafraction motion produced directionally asymmetric coverage loss, with the largest effect on the boosted GTV, and motion-inclusive dose reconstruction enabled derivation of practical asymmetric margins that improved robustness while identifying the tradeoff between target coverage and delivery efficiency.
Abstract
Purpose: To quantify the dosimetric effect of residual intrafraction motion during gated MR-guided prostate stereotactic body radiotherapy with simultaneous integrated boost to the dominant intraprostatic lesion, and to derive and evaluate target-specific, population-based margins designed to mitigate motion-induced coverage loss. Materials and Methods: Thirty patients were treated on a 1.5-T MR-Linac with 36.25, 40, and 45 Gy prescribed to the planning target volume, clinical target volume (CTV), and gross tumor volume (GTV), in 5 fractions. Across 150 fractions, segment-level dose matrices synchronized with time-resolved target displacements were combined to reconstruct per-fraction and cumulative dose. Directional prescription-isodose deviations were used to derive internal target volume margins, which were evaluated through offline replanning, gating-envelope analysis, and dose reconstruction. Results: Median 95th-percentile motion ranges were 0.5, 1.4, and 2.9 mm in the left-right, anterior-posterior, and superior-inferior directions; these exceeded 3 mm in 0.7%, 13.2%, and 47.7% of fractions, respectively. The median treatment time was 13.2 min (IQR, 12.0-15.1 min) with a median gating duty cycle of 93.2% (80.6%-97.8%). Per-fraction median GTV deviations were -1.2% (-2.4% to -0.1%) for D95 and -5.6% (-15.3% to -0.2%) for V45Gy; corresponding CTV deviations were -0.5% (-1.1% to -0.1%) and -2.1% (-4.1% to -0.4%). Cohort-derived margins of 2/2/1/2/1/2 mm for the GTV and 1/1/1/2/1/2 mm for the CTV in the left/right/anterior/posterior/superior/inferior directions achieved sufficient coverage in approximately 94% of fractions in each direction. Gated delivery using the proposed margins improved coverage but may reduce duty cycle by an average of 6.9 +/- 4.7 %. Conclusion: Residual intrafraction motion produced directionally asymmetric coverage loss, with the largest effect on the boosted GTV. Motion-inclusive dose reconstruction enabled derivation of practical asymmetric margins that improved robustness while identifying the tradeoff between target coverage and delivery efficiency.
Proton therapy has been increasingly utilized in head and neck cancer (HNC) patients due to its unique property of the Bragg Peak. However, proton dose delivery is highly sensitive to positional variations and anatomical changes occurring during the treatment course. These changes can lead to deviations between planned...
Daily CBCT image-guided couch corrections maintain dosimetric accuracy during hypofractionated prostate radiotherapy and support safe implementation of tight PTV margins in resource-constrained public-sector healthcare settings.
Leanore Legoale-Sebopa, Sheynaz Bassa, H. V. Maselesele· South African Journal of Onc...· 0 citations
For lung metastases lying within 5 mm of the esophagus, organ-at-risk dose limits often force the prescription below the ablative range, lowering biologically effective dose and tumor control. We evaluated whether a simultaneous integrated boost to the tumor core, rather than dose reduction, is dosimetrically and radio...
I. H. Suyusal, O. Çolak, Ahmet Karagöz· Medical Dosimetry· 0 citations
Objective: In high-dose-rate brachytherapy for cervical cancer, cumulative dose is commonly estimated using simple summation (SS) of dose–volume histogram parameters, assuming high-dose regions remain spatially consistent across fractions. Deformable image registration (DIR) offers an alternative approach that accounts...
Chitchaya Suwanraksa, Bheampos Rojkitjanuruk, Tanapat Suwanpan et al.· Journal of Health Science an...· 0 citations
OBJECTIVES
To compare the dosimetric performance of HyperArc (HA) and intensity-modulated proton therapy (IMPT) for total scalp irradiation (TSI) in patients with angiosarcoma of the scalp (AS).
METHODS
HA and IMPT treatment plans were retrospectively generated for 27 patients with AS. Prescription doses of 70 and 56...
S. Inui, N. Tomita, T. Takaoka et al.· British Journal of Radiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.